Horizon Therapeutics USA, Inc. drugs
9 results
Actimmune (interferon gamma-1b)
(Interferon gamma-1b)Horizon Therapeutics USA, Inc.
Usage: ACTIMMUNE is indicated for reducing the frequency and severity of serious infections in patients with Chronic Granulomatous Disease (CGD) and for delaying disease progression in those with severe, malignant osteopetrosis (SMO).
Duexis (ibuprofen and famotidine)
(Ibuprofen and Famotidine)Horizon Therapeutics USA, Inc.
Usage: DUEXIS is indicated for relieving symptoms of rheumatoid arthritis and osteoarthritis, and for reducing the risk of upper gastrointestinal ulcers in patients using ibuprofen for these conditions. Clinical trials primarily involved patients under 65 without a history of gastrointestinal ulcers.
Krystexxa (pegloticase)
(pegloticase)Horizon Therapeutics USA, Inc.
Usage: KRYSTEXXA (pegloticase) is indicated for the treatment of chronic gout in adult patients who have not responded to conventional therapy, specifically those who cannot normalize serum uric acid with xanthine oxidase inhibitors or have contraindications to these medications. It is not recommended for asymptomatic hyperuricemia.
Pennsaid (diclofenac sodium)
(diclofenac sodium)Horizon Therapeutics USA, Inc.
Usage: PENNSAID is indicated for treating knee pain associated with osteoarthritis.
Procysbi (cysteamine bitartrate)
(Cysteamine bitartrate)Horizon Therapeutics USA, Inc.
Usage: PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients aged 1 year and older.
Rayos (prednisone)
(prednisone)Horizon Therapeutics USA, Inc.
Usage: RAYOS is indicated for severe allergic conditions, dermatologic diseases, endocrine and gastrointestinal disorders, hematologic diseases, neoplastic conditions, nervous system issues, ocular inflammation, organ transplant rejection, pulmonary diseases, renal conditions, rheumatologic disorders, and certain infectious diseases, particularly those with severe manifestations.
Tepezza (teprotumumab)
(teprotumumab)Horizon Therapeutics USA, Inc.
Usage: TEPEZZA is indicated for the treatment of Thyroid Eye Disease, applicable to all patients regardless of the disease's activity or duration.
Uplizna (inebilizumab)
(Inebilizumab)Horizon Therapeutics USA, Inc.
Usage: UPLIZNA is indicated for treating neuromyelitis optica spectrum disorder (NMOSD) in adults who are anti-aquaporin-4 antibody positive and for treating Immunoglobulin G4-related disease (IgG4-RD) in adults.
Vimovo (naproxen and esomeprazole magnesium)
(Naproxen and Esomeprazole Magnesium)Horizon Therapeutics USA, Inc.
Usage: VIMOVO, combining naproxen and esomeprazole magnesium, is indicated for adults and adolescents (12+) requiring naproxen for arthritis symptom relief while reducing the risk of gastric ulcers. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis but is not for initial acute pain treatment.